Volume 40, Issue 1 supplement | PharmacoEconomics

Search all PharmacoEconomics articles

Volume 40, Issue 1 supplement

April 2022

Assessing the Value of Treatments for Spinal Muscular Atrophy

Issue Editors:

Chris D. Skedgel,
Nicole Gusset

10 articles in this issue

PharmacoEconomics

Announcement 28 March 2022 Pages: 1 - 1
Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain
Chris Skedgel
Editorial 22 December 2021 Pages: 3 - 5
Importance of Patient Involvement in the Value Assessment Process: On the Way Towards Personalised Treatments
Nicole Gusset
Editorial 16 December 2021 Pages: 7 - 10
Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
Noman Paracha
Pollyanna Hudson
C. Simone Sutherland
Systematic Review Open access 11 November 2021 Pages: 11 - 38
Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers
C. Simone Sutherland
Pollyanna Hudson
Noman Paracha
Systematic Review Open access 15 December 2021 Pages: 39 - 67
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Noman Paracha
Pollyanna Hudson
C. Simone Sutherland
Systematic Review Open access 18 October 2021 Pages: 69 - 89
Preferences and Utilities for Treatment Attributes in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy in the United Kingdom
Siu Hing Lo
Ksenija Gorni
Noman Paracha
Original Research Article Open access 18 October 2021 Pages: 91 - 102
Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries
Siu Hing Lo
Claire Lawrence
Andrew J. Lloyd
Original Research Article Open access 13 December 2021 Pages: 103 - 115
Correction to: Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain
Chris Skedgel
Correction 25 February 2022 Pages: 117 - 117
Correction to: Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Noman Paracha
Pollyanna Hudson
C. Simone Sutherland
Correction Open access 26 February 2022 Pages: 119 - 119